Developing a mass spectrometric assay to measure granulin peptides in CSF for progranulin‐associated frontotemporal dementia

Imogen J. Swift(UK Dementia Research Institute), Johan Gobom(Sahlgrenska University Hospital), Ann Brinkmalm(Sahlgrenska University Hospital), Caroline Graff(Karolinska Institutet), Maria Carmela Tartaglia, James B. Rowe(MRC Cognition and Brain Sciences Unit), Alexander Gerhard(University of Manchester), Christopher Butler(Pontificia Universidad Católica de Chile), Matthis Synofzik(University of Tübingen), Johannes Levin(The University of Melbourne), Sophia Weiner(Institute of Neurobiology), Alexandre de Mendonça(University of Lisbon), Isabelle Le Ber(Inserm), Raquel Sánchez‐Valle(Universitat de Barcelona), Mathias Sauer(Sahlgrenska University Hospital), Harro Seelaar(Erasmus University Rotterdam), Aitana Sogorb‐Esteve(UK Dementia Research Institute), Pietro Tiraboschi(Mayo Clinic in Florida), Florence Pasquier, Isabel Santana(University of Coimbra), Lize C. Jiskoot(Erasmus MC), Jonathan D. Rohrer(UK Dementia Research Institute), Markus Otto(Universität Ulm), Rik Vandenberghe(KU Leuven), Johanna Nilsson(University of Gothenburg), Elizabeth Finger(Western University), Henrik Zetterberg(Queen Mary University of London), Daniela Galimberti(University of Milan), Fermín Moreno(Instituto de Salud Carlos III), Robert Laforce(Université Laval), Barbara Borroni(Anna Needs Neuroblastoma Answers), Mario Masellis(Sunnybrook Health Science Centre), Simon Ducharme(Montreal Neurological Institute and Hospital), John C. van Swieten(Erasmus MC), Sandro Sorbi(University of Florence)
Alzheimer s & Dementia
December 1, 2023
Cited by 0


Related Papers